微量肝素静滴联合氨溴索雾化吸入辅助治疗支气管肺炎疗效观察

Observation of Curative Effect of Micro Heparin Intravenously and Ambroxol Aerosol Inhalation on Bronchopneumonia

目的:探讨微量肝素静滴联合氨溴索雾化吸入辅助治疗支气管肺炎疗效。方法:将82例支气管肺炎患儿随机分为治疗组(n=42)和对照组(n=40),其中治疗组为在综合治疗的基础上加用微量肝素静滴联合氨溴索雾化吸入治疗,连续应用5d。氨溴索采用超声雾化器进行雾化吸入,连用5d。结果:治疗组临床观察咳嗽,呼吸困难,肺部罗音消失时间,平均治疗天数均较对照组缩短,各项指标统计处理两组差异有显著性意义(P<0.01)。结论:支气管肺炎在综合治疗的基础上加用微量肝素静滴联合氨溴索雾化吸入治疗疗效显著。

Objective：To explore the the curative effect of micro heparin intravenously and ambroxol aerosol inhalation on bronchopneumonia. Method： 82 cases with bronchopneumonia were randomly divided into two groups, the therapeutic group{ N = 42） and the control group （N = 40）. The therapeutic group was given micro heparin intravenously and arnbroxol aerosol inhalation for 5 days on the basis of combined thera- py. Result： The time to remove fever, cough, dyspnea and pulmonary tales and average therapeuti c period was shorter （ P 〈0.05 } than that in the control group, there was significant difference { P 〈 0.01 } between the therapeutic group and the control group. Conclusion： The micro heparin intravenously and ambroxol aerosol inhalation on bronchopneumonia on the basis of combined therapy has significant curative effect.